Ensign Peak Advisors, Inc Denali Therapeutics Inc. Transaction History

Ensign Peak Advisors, Inc

  • $51.2 Billion
  • Q1 2025

A detailed history of Ensign Peak Advisors, Inc transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 587,785 shares of DNLI stock, worth $8.04 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
587,785
Previous 346,304 69.73%
Holding current value
$8.04 Million
Previous $7.06 Million 13.26%
% of portfolio
0.02%
Previous 0.01%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
BUY
$13.6 - $23.59 $3.28 Million - $5.7 Million
241,481 Added 69.73%
587,785 $7.99 Million
Q1 2024

May 14, 2024
SELL
$15.83 - $23.35 $34,715 - $51,206
-2,193 Reduced 0.63%
346,304 $7.11 Million
Q3 2023

Nov 13, 2023
BUY
$20.63 - $30.17 $4.13 Million - $6.03 Million
200,000 Added 134.68%
348,497 $7.19 Million
Q2 2023

Aug 14, 2023
BUY
$23.37 - $32.96 $92,311 - $130,192
3,950 Added 2.73%
148,497 $4.38 Million
Q1 2023

May 15, 2023
BUY
$21.91 - $32.67 $43,820 - $65,340
2,000 Added 1.4%
144,547 $3.33 Million
Q4 2022

Feb 13, 2023
BUY
$26.28 - $33.92 $522,972 - $675,008
19,900 Added 16.23%
142,547 $3.96 Million
Q3 2022

Nov 14, 2022
BUY
$25.97 - $38.53 $960,240 - $1.42 Million
36,975 Added 43.16%
122,647 $3.76 Million
Q2 2022

Aug 12, 2022
SELL
$20.88 - $35.19 $394,715 - $665,231
-18,904 Reduced 18.08%
85,672 $2.52 Million
Q1 2022

May 16, 2022
BUY
$29.0 - $47.27 $3,480 - $5,672
120 Added 0.11%
104,576 $3.37 Million
Q4 2021

Feb 11, 2022
BUY
$42.59 - $55.02 $1.62 Million - $2.1 Million
38,108 Added 57.44%
104,456 $4.66 Million
Q3 2021

Nov 12, 2021
BUY
$48.48 - $78.23 $1.18 Million - $1.91 Million
24,406 Added 58.19%
66,348 $3.35 Million
Q2 2021

Aug 13, 2021
BUY
$50.3 - $78.44 $15,090 - $23,532
300 Added 0.72%
41,942 $3.29 Million
Q1 2021

May 12, 2021
SELL
$53.8 - $81.53 $875,864 - $1.33 Million
-16,280 Reduced 28.11%
41,642 $2.38 Million
Q4 2020

Feb 12, 2021
BUY
$36.89 - $93.56 $7,414 - $18,805
201 Added 0.35%
57,922 $4.85 Million
Q3 2020

Nov 12, 2020
BUY
$23.13 - $38.84 $9,575 - $16,079
414 Added 0.72%
57,721 $2.07 Million
Q2 2020

Aug 12, 2020
SELL
$16.01 - $28.82 $1.09 Million - $1.96 Million
-67,842 Reduced 54.21%
57,307 $1.39 Million
Q1 2020

May 11, 2020
BUY
$14.2 - $27.98 $1.66 Million - $3.28 Million
117,173 Added 1469.07%
125,149 $2.19 Million
Q4 2019

Feb 14, 2020
BUY
$14.4 - $19.99 $114,854 - $159,440
7,976 New
7,976 $139,000

Others Institutions Holding DNLI

# of Institutions
235
Shares Held
127M
Call Options Held
37.3K
Put Options Held
7.9K
View Full List

About Denali Therapeutics Inc.

DNLI Quotes by TradingView
  • Ticker DNLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 134,174,000
  • Market Cap $1.83B
  • Description
  • Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...
More about DNLI
Track This Portfolio

Track Ensign Peak Advisors, Inc Portfolio

Follow Ensign Peak Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email